AGL 40.08 Increased By ▲ 0.05 (0.12%)
AIRLINK 127.85 Increased By ▲ 0.15 (0.12%)
BOP 6.74 Increased By ▲ 0.13 (1.97%)
CNERGY 4.47 Decreased By ▼ -0.13 (-2.83%)
DCL 8.90 Increased By ▲ 0.11 (1.25%)
DFML 41.70 Increased By ▲ 0.12 (0.29%)
DGKC 86.85 Increased By ▲ 1.06 (1.24%)
FCCL 32.80 Increased By ▲ 0.31 (0.95%)
FFBL 64.51 Increased By ▲ 0.48 (0.75%)
FFL 11.36 Increased By ▲ 0.81 (7.68%)
HUBC 111.55 Increased By ▲ 0.78 (0.7%)
HUMNL 14.90 Decreased By ▼ -0.17 (-1.13%)
KEL 4.97 Increased By ▲ 0.09 (1.84%)
KOSM 7.38 Decreased By ▼ -0.07 (-0.94%)
MLCF 40.90 Increased By ▲ 0.38 (0.94%)
NBP 61.50 Increased By ▲ 0.45 (0.74%)
OGDC 194.80 Decreased By ▼ -0.07 (-0.04%)
PAEL 27.48 Decreased By ▼ -0.03 (-0.11%)
PIBTL 7.78 Decreased By ▼ -0.03 (-0.38%)
PPL 153.21 Increased By ▲ 0.68 (0.45%)
PRL 26.70 Increased By ▲ 0.12 (0.45%)
PTC 16.15 Decreased By ▼ -0.11 (-0.68%)
SEARL 84.49 Increased By ▲ 0.35 (0.42%)
TELE 7.90 Decreased By ▼ -0.06 (-0.75%)
TOMCL 36.80 Increased By ▲ 0.20 (0.55%)
TPLP 8.86 Increased By ▲ 0.20 (2.31%)
TREET 17.12 Decreased By ▼ -0.54 (-3.06%)
TRG 57.89 Decreased By ▼ -0.73 (-1.25%)
UNITY 26.78 Decreased By ▼ -0.08 (-0.3%)
WTL 1.34 Decreased By ▼ -0.04 (-2.9%)
BR100 10,000 No Change 0 (0%)
BR30 31,002 No Change 0 (0%)
KSE100 94,634 Increased By 442.2 (0.47%)
KSE30 29,380 Increased By 179.2 (0.61%)

According to newspaper reports Federal Minister for Health Mir Aijaz Hussain Jakhrani said the ministry had increased prices of some drugs from 15 to 45 percent, terming the increase as inevitable.
The minister supported the increase and said the raise was unavoidable owing to the reason that cost of manufacturing the drugs had increased and the current prices of these medicines were making it virtually impossible for the related pharmaceutical companies to produce them.
This is the official confirmation of drugs price hike otherwise pharmaceutical companies have increased the prices manifold before the approval by the ministry.
Officially the increase is only 45 percent but the real increase is more than that. There is no doubt that the cost of production must have increased but the pharma industry has done injustice by unilaterally doing this and forcing the government to accept this. Manufacturers also indulge in unfair practices by creating an artificial shortage of medicines.
A multivitamin syrup, which was available at Rs 40 before shortage and after a reasonable period its price was increased to Rs 65. The government must take steps to curb this tendency and save the poor from being fleeced.

Copyright Business Recorder, 2009

Comments

Comments are closed.